Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘(NASDAQ:SCLN)’

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

13D Filing: Gl Partners Capital Management Ltd and Sciclone Pharmaceuticals Inc (SCLN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing   UNITED STATES SECURITIES AND EXCHANGE......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Hedge Funds Are Buying SciClone Pharmaceuticals, Inc. (SCLN)

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of......(read more)
lab, scientist, tech, chemistry, test, experiment, reaction, pharmaceutical, medical, liquid, fluid, dropper, tool, pharmacology, sample, organic, pipette, drug, chemist, bio

Hedge Funds Aren’t Crazy About SciClone Pharmaceuticals, Inc. (SCLN) Anymore

The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil......(read more)
stocks, analysis, market, numbers, business, ticket, trade, money, price

Here Is Why These Four Stocks Stand Out from the Crowd on Tuesday

All major U.S. stock indexes slide into negative territory in early trading on Tuesday, after having registered losses of over 1% on Monday. The Dow Jones......(read more)
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

Should You Buy Surging SciClone Pharmaceuticals (SCLN), Up By 14.66% Today?

SciClone Pharmaceuticals Inc (NASDAQ:SCLN) is a $503.65 million market cap company which serves as a provider of therapies for oncology, infectious diseases......(read more)
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

GL Partners Adds to Position in SciClone Pharmaceuticals; Reveals New Stake in China Biologic Products

GL Partners Capital Management has increased the holding of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) stock. In a recent filing with the Securities......(read more)
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

Do Hedge Funds and Insiders Love SciClone Pharmaceuticals, Inc. (SCLN)?

What’s a smart SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) investor to do? In the 21st century investor’s toolkit, there are tons of indicators......(read more)
Depomed Inc (NASDAQ:DEPO)

Depomed Inc (DEPO): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?

Should Depomed Inc (NASDAQ:DEPO) investors track the following data? In the eyes of many market players, hedge funds are viewed as delayed, outdated......(read more)
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)

Is Sucampo Pharmaceuticals, Inc. (SCMP) Going to Burn These Hedge Funds?

Is Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) the right investment to pursue these days? Hedge funds are turning bullish. The number of long hedge fund......(read more)
Pernix Therapeutics Holdings Inc (PTX)

Pernix Therapeutics Holdings Inc (PTX): Are Hedge Funds Right About This Stock?

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) has seen an increase in activity from the world’s largest hedge funds of late. In the financial world......(read more)
Depomed Inc (NASDAQ:DEPO)

Depomed Inc (DEPO): Hedge Funds and Insiders Are Bullish, What Should You Do?

Depomed Inc (NASDAQ:DEPO) was in 13 hedge funds’ portfolio at the end of the first quarter of 2013. DEPO shareholders have witnessed an increase......(read more)
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

SciClone Pharmaceuticals, Inc. (SCLN): Insiders Are Buying, Should You?

SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) shareholders have witnessed a decrease in support from the world’s most elite money managers of late......(read more)
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

SciClone Pharmaceuticals, Inc. (SCLN): Insiders Aren’t Crazy About It

Is SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) an attractive investment today? The best stock pickers are becoming more confident. The number of long......(read more)
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

Here is What Hedge Funds Think About SciClone Pharmaceuticals, Inc. (SCLN)

SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) investors should be aware of an increase in activity from the world’s largest hedge funds lately. In......(read more)